Next Article in Journal
Inherent Properties of Smart Tensegrity Structures
Next Article in Special Issue
Recent Advances in Nanocomposites Based on Aliphatic Polyesters: Design, Synthesis, and Applications in Regenerative Medicine
Previous Article in Journal
Efficiently Answering Reachability Queries for Tree-Structured Data in Repetitive Prime Number Labeling Schemes
Previous Article in Special Issue
Neuroprotective Investigation of Chitosan Nanoparticles for Dopamine Delivery
Article Menu
Issue 5 (May) cover image

Export Article

Open AccessArticle
Appl. Sci. 2018, 8(5), 786; https://doi.org/10.3390/app8050786

Nanostructured Composites of Sodium Montmorillonite Clay and PEO Used in Dissolution Improvement of Aprepitant Drug by Melt Mixing

1
Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
2
Department of Materials Science and Engineering, University of Ioannina, 45110 Ioannina, Greece
*
Author to whom correspondence should be addressed.
Received: 28 March 2018 / Revised: 27 April 2018 / Accepted: 9 May 2018 / Published: 15 May 2018
(This article belongs to the Special Issue Eco-Friendly Nanocomposites for Biomedical Applications)
Full-Text   |   PDF [6617 KB, uploaded 15 May 2018]   |  

Abstract

In this work, aprepitant (APR) was loaded in a high-molecular-weight poly(ethylene oxide) (PEO) and PEO/clay nanocomposites via the melt-mixing process in order to investigate the combined effect of the PEO and PEO/clay phases on the dissolution profile of APR. Various drug (5, 10, 20 wt %) and Cloisite-Na+ microgranuled nanoclay (5 and 10 wt %) loadings were used for the preparation of the solid dispersions using a twin screw melt mixer at temperatures below the drug’s melting point. X-ray diffraction (XRD) and infrared (FTIR) data of the prepared formulations confirmed that the semicrystalline structure of the PEO and the structure of APR have remained intact. The PEO chain intercalation in the intragallery space between the clay nanolayers was also confirmed by XRD, especially in the APR/PEO formulations containing 5 wt % microgranuled nanoclay. The in vitro release study demonstrated that in all formulations, the dissolution rate of APR was substantially enhanced compared to neat drug. Immediate release formulations have been prepared, and the combination of PEO/5 wt % clay nanocomposite phase with 5 or 10 wt % drug loading gives much higher maximum dissolution (reaching 98 and 85%, respectively) compared to the neat drug (40%). This improved performance was attributed to the highly intercalated/exfoliated state of clay nanolayers in the APR/PEO/5 wt % clay formulations. A model was also investigated to explain the physical mechanism of drug release in all formulations. View Full-Text
Keywords: aprepitant (APR); poly(ethylene oxide) (PEO); sodium montmorillonite clay (Cloisite-Na+); melt mixing; enhanced dissolution profile aprepitant (APR); poly(ethylene oxide) (PEO); sodium montmorillonite clay (Cloisite-Na+); melt mixing; enhanced dissolution profile
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Pappa, C.; Nanaki, S.; Giliopoulos, D.; Triantafyllidis, K.; Kostoglou, M.; Avgeropoulos, A.; Bikiaris, D. Nanostructured Composites of Sodium Montmorillonite Clay and PEO Used in Dissolution Improvement of Aprepitant Drug by Melt Mixing. Appl. Sci. 2018, 8, 786.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Appl. Sci. EISSN 2076-3417 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top